latest-news-headlines Market Intelligence /marketintelligence/en/news-insights/latest-news-headlines/apollomics-raises-124m-in-series-c-round-61172308 content esgSubNav
In This List

Apollomics raises $124M in series C round

Blog

Global M&A By the Numbers: Q3 2021

Blog

Insight Weekly: Global stock performance; hydrogen pilot projects; Powell's Fed future unsure

Blog

How Financial Institutions are Managing Exposure to U.S. Municipals

Blog

Top 100 Banks: Capital Ratios Show Resilience to the Pandemic


Apollomics raises $124M in series C round

Apollomics Inc. raised $124.2 million at the close of its series C funding round led by China's Ping An Capital Co. Ltd.

The biopharmaceutical company will use the proceeds to support the development of its pipeline.

Based in Foster City, Calif., Apollomics develops medicines for targeting the growth and proliferation of cancer cells.